Research
Prescription, supplement, or research chemical
Three kinds of seller use the same product photography and the same vocabulary. Federal law puts them in three different categories with three different sets of duties, and the tells are printed on the label.
One word, three counters
Search for a peptide and the results mix three businesses that have almost nothing in common underneath.
One is a telehealth service that routes a prescription to a compounding pharmacy. One sells a capsule, a powder or a spray as a dietary supplement, with no prescriber anywhere in the flow. One ships a vial labeled for research use only, as a laboratory chemical.
The pages look alike because the marketing conventions of the category are shared. The legal categories are not, and each one carries a different answer to the question of who checked what.
The prescription channel and the research channel are covered elsewhere on this site in their own detail. The supplement channel is the one this walks through, because it is the one whose rules are least often stated.
What a dietary supplement legally is
The definition is a federal one, and it has three parts that all have to hold.
The product has to be intended to supplement the diet and to bear or contain at least one dietary ingredient. The listed ingredients are a vitamin, a mineral, an herb or other botanical, and an amino acid. The list continues with a dietary substance for use by man to supplement the diet by increasing total dietary intake. It closes with a concentrate, metabolite, constituent, extract or combination of any of those.
It has to be intended for ingestion, and it must not be represented for use as a conventional food or as the sole item of a meal or the diet. It also has to be labeled as a dietary supplement.
Then comes the part that decides most arguments in this category. The definition expressly does not include an article approved as a new drug. It also excludes an article authorized for investigation as a new drug, where substantial clinical investigations have been instituted and made public. Both exclusions apply where the article was not marketed as a dietary supplement or as a food beforehand.
That clause is a sequencing rule. A substance that entered the drug development pathway before anyone sold it as a supplement cannot be moved onto the supplement counter afterward, unless the agency issues a regulation after notice and comment.
Amino acid appears in the ingredient list, which is why the category attracts peptide products at all. The exclusion sits three subparagraphs later, and it is doing most of the work.
The seventy-five day letter
A supplement containing a new dietary ingredient is deemed adulterated unless it meets one of two conditions, and only two.
The first is that the supplement contains only dietary ingredients present in the food supply as an article used for food, in a form in which the food has not been chemically altered.
The second is a notification. There has to be a history of use or other evidence of safety supporting a reasonable expectation of safety under the labeled conditions. And at least seventy-five days before the ingredient enters interstate commerce, the manufacturer or distributor has to give the agency the information that conclusion rests on, including citations to published articles.
The agency keeps that submission confidential for ninety days. After that it goes on public display, minus trade secrets and confidential commercial information.
So a notification is a document with a date, sitting in a public file. It is not an approval, and the statute never calls it one. It is the manufacturer stating its safety basis in advance and the agency having the chance to respond.
What a supplement label may and may not say
A supplement may carry a statement describing the role of a nutrient or dietary ingredient intended to affect the structure or function of the body. The statement may also characterize the documented mechanism by which that ingredient acts, or describe general well-being from consuming it.
Three conditions attach. The manufacturer has to hold substantiation that the statement is truthful and not misleading. The statement may not claim to diagnose, mitigate, treat, cure or prevent a specific disease or class of diseases. And the label has to carry a sentence, prominently displayed and in boldface type. It says the statement has not been evaluated by the Food and Drug Administration, and that the product is not intended to diagnose, treat, cure or prevent any disease.
There is also a filing. Where a manufacturer proposes to make such a statement in labeling, it has to notify the agency no later than thirty days after first marketing the supplement with it.
Read the disclaimer for what it actually asserts. It is not a warning about the ingredient. It is a statement that the claim beside it was not reviewed, which is a fact about the process rather than about the product.
The bar on disease claims is the line that supplement marketing crosses most visibly. A page that promises a supplement will treat, prevent or cure a named condition has made the kind of claim the structure and function allowance does not cover.
The panel is the fastest visual tell
A dietary supplement offered for sale has to bear nutrition labeling in a prescribed format, under the heading Supplement Facts.
Underneath that heading sits a Serving Size subheading, and the serving size is expressed in a term appropriate to the form, such as tablets, capsules, packets or teaspoonfuls. Servings Per Container follows it.
That panel is a fast discriminator on a product photograph. A Supplement Facts panel and a boldface disclaimer say the seller has placed the product on the supplement counter, whatever the rest of the page implies.
A dispensed prescription arrives instead with a pharmacy label bearing the dispenser, the prescription serial number and date, the prescriber and the directions. Those two labels are not variants of each other.
The prescription counter, in two sentences
A drug that is not safe for use except under professional supervision may be dispensed only on a prescription. The same applies where an approved application limits the drug to such supervision. The prescription has to be the written or oral prescription of a practitioner licensed by law to administer it, or a refill the prescriber authorized.
Separately, no new drug may be introduced or delivered for introduction into interstate commerce unless an approval of an application is effective for it. Those two provisions sit behind everything the prescription channel does, and this site covers their consequences in detail elsewhere.
The practical marker is a person. Somewhere in a prescription flow there is a licensed prescriber who is accountable for a decision, and a pharmacy that filled it. On the supplement counter there is no such person, by design.
The third counter, and why it is not a middle ground
A vial labeled for research use only is being offered as a laboratory chemical rather than as a medicine or a supplement. It sits outside both of the frameworks above.
The label is a statement by the seller about intended use, and it does not settle the legal question by itself. What a seller says elsewhere on the same site can contradict it.
This site treats that channel in its own article, and nothing here shortens it. The point for a buyer comparing three tabs is only that a research-use vial is not a lightly regulated version of either of the other two.
Six questions that place a seller
Does a licensed prescriber decide, and is that person or that clinician group identified anywhere on the site?
Does the product page show a Supplement Facts panel, and does the label carry the boldface disclaimer?
Is a pharmacy named, and does the seller distinguish a compounding pharmacy from a fulfillment warehouse?
Does the page make a disease claim, and does the channel it is selling on permit one?
Does the vial or bottle carry a research use only statement anywhere, including in small print on a certificate or an order page?
Does the checkout ask a health history at all, and does anything in the flow depend on the answers?
Key takeaways
- Three businesses sell under the same vocabulary: a prescription channel, a supplement channel and a research chemical channel.
- The federal definition of a dietary supplement lists an amino acid as a dietary ingredient, then excludes articles that entered the drug pathway first.
- A new dietary ingredient needs a notification at least seventy-five days before it is introduced, and that notification is not an approval.
- A structure or function claim requires substantiation, bars disease claims, and brings a required boldface disclaimer with it.
- A Supplement Facts panel and a pharmacy label are different documents, and either one tells you which counter you are standing at.
- Which counter a specific substance belongs on is a product-by-product question with a dated answer, not a property of the molecule.
Frequently asked questions
Can a peptide be sold as a dietary supplement?
The ingredient list in the federal definition includes an amino acid, which is why the question arises. The same definition then excludes an article approved as a new drug. It also excludes an article authorized for investigation as a new drug, where substantial clinical investigations have been instituted and made public. Both exclusions bite only if the article was not marketed as a supplement or a food before that point. So the answer depends on the specific substance and on what happened first in its history, not on the chemistry alone. It is a product-by-product question with a dated answer.
What does the disclaimer on a supplement bottle mean?
It is the sentence federal law requires in boldface beside a structure or function statement. The sentence says the statement has not been evaluated by the Food and Drug Administration, and that the product is not intended to diagnose, treat, cure or prevent any disease. It reports that the claim next to it was not reviewed. It is not a safety warning about the ingredient, and it is not an admission that the product does nothing.
What is a new dietary ingredient notification?
It is a submission a manufacturer or distributor has to make at least seventy-five days before introducing a new dietary ingredient into interstate commerce. It sets out the history of use or other evidence of safety the conclusion rests on. The agency keeps it confidential for ninety days and then places it on public display, less trade secrets and confidential commercial information. It is a notification, not an approval, and the statute never treats it as one.
How do I tell a supplement from a prescription product by looking?
The panel and the label are the fastest signals. A supplement carries nutrition labeling under a Supplement Facts heading with a serving size in tablets, capsules, packets or teaspoonfuls, and a structure or function claim brings the boldface disclaimer with it. A dispensed prescription arrives with a pharmacy label naming the dispenser, the prescription serial number and date, the prescriber and the directions. A research-use vial carries neither.
Does a supplement seller need a prescriber?
No, and that is the defining difference rather than an oversight. The supplement framework has no prescriber in it, which is why the same framework bars disease claims and requires the disclaimer. A seller that has no clinician and also makes claims about treating a condition has combined the freedom of one counter with the claims of another.
Is a supplement version of a compound the same thing more cheaply?
The name on the front is the weakest thing two products can share. Different channels carry different duties about identity, purity, claims and who is accountable, and the price difference usually reflects which set applies rather than a better deal on the same item. Establish which counter a seller is standing behind before comparing anything else about it.
Sources
Each document below is named as it names itself, with the date printed on that document rather than the day it was read.
- United States Code Title 21, Section 321, Definitions, including the definition of dietary supplement at subsection (ff), 2024 Main Edition — Office of the Law Revision Counsel, U.S. House of Representatives, January 2025
- United States Code Title 21, Section 350b, New dietary ingredients, 2024 Main Edition — Office of the Law Revision Counsel, U.S. House of Representatives, January 2025
- United States Code Title 21, Section 343, Misbranded food, including the structure and function statement conditions at subsection (r)(6), 2024 Main Edition — Office of the Law Revision Counsel, U.S. House of Representatives, January 2025
- Title 21 Code of Federal Regulations Section 101.36, Nutrition labeling of dietary supplements — Electronic Code of Federal Regulations, Office of the Federal Register, December 2018
- United States Code Title 21, Section 353, Exemptions and consideration for certain drugs, devices, and biological products, 2024 Main Edition — Office of the Law Revision Counsel, U.S. House of Representatives, January 2025
- United States Code Title 21, Section 355, New drugs, 2024 Main Edition — Office of the Law Revision Counsel, U.S. House of Representatives, January 2025